Harnessing surface engineering strategies to functionalize nucleic acid-lipid nanoparticles (LNPs) for improved performance has been a hot research topic since the approval of the first siRNA drug, ...
Lipid nanoparticles (LNPs) have emerged as a powerful delivery platform for nucleic acid-based treatments, driven by innovations in lipid composition and formulation techniques. As therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results